Gss and Gsr expression levels are downregulated together with Gpx4 in the tumor areas which shows that GO-PEI-PEG/PD-L1 siRNAs and sorafenib together could immensely produce anti-tumor immunity actions which improve ferroptosis in vivo [219]. This evidence concerns the gene GSR and neoplasm.